Reports on the prevalence of clinical conditions are more convincing when supported by objective evidence.

by Julius Schachter, Robin Bailey, Chandler R Dawson, Thomas M Lietman
Published 2008-09-01

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma

by Kevin Cyrus Hong, Julius Schachter, Jeanne Moncada, Zhaoxia Zhou, Jenafir House, Thomas M. Lietman
Published 2009-07-01

Slow Epidemic of Lymphogranuloma Venereum L2b Strain

by Joke Spaargaren, Julius Schachter, Jeanne Moncada, Henry J.C. de Vries, Han S.A. Fennema, A. Salvador Peña, Roel A. Coutinho, Servaas A. Morré
Published 2005-11-01

Eliminating Trachoma in Areas with Limited Disease

by Bruce D. Gaynor, Yinghui Miao, Vicky Cevallos, Hem Jha, JSP Chaudary, Ramesh Bhatta, Susan Osaki-Holm, Elizabeth Yi, Julius Schachter, John P. Whitcher, Thomas Lietman
Published 2003-05-01

Risk factors for ocular chlamydia after three mass azithromycin distributions.

by Berhan Ayele, Teshome Gebre, Jeanne Moncada, Jenafir I House, Nicole E Stoller, Zhaoxia Zhou, Travis C Porco, Bruce D Gaynor, Paul M Emerson, Julius Schachter, Jeremy D Keenan
Published 2011-12-01

Typing of Lymphogranuloma Venereum Chlamydia trachomatis Strains

by Linus Christerson, Henry J.C. de Vries, Bertille de Barbeyrac, Charlotte A. Gaydos, Birgit Henrich, Steen Hoffmann, Julius Schachter, Johannes Thorvaldsen, Martí Vall-Mayans, Markus Klint, Björn Herrmann, Servaas A. Morré
Published 2010-11-01

Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopi...

by Scott D Nash, Ambahun Chernet, Jeanne Moncada, Aisha E P Stewart, Tigist Astale, Eshetu Sata, Mulat Zerihun, Demelash Gessese, Berhanu Melak, Gedefaw Ayenew, Zebene Ayele, Melsew Chanyalew, Thomas M Lietman, E Kelly Callahan, Julius Schachter, Zerihun Tadesse
Published 2020-05-01